Skip to Content

Pfizer 400 (Bosulif 400 mg)

Generic Name: bosutinib

Pill with imprint Pfizer 400 is Orange, Elliptical / Oval and has been identified as Bosulif 400 mg. It is supplied by Pfizer Inc..

Bosulif is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer 400

Bosulif 400 mg Pfizer 400

Bosulif

Generic Name
bosutinib
Imprint
Pfizer 400
Strength
400 mg
Color
Orange
Size
18.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0193
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, povidone k25, magnesium stearate, titanium dioxide, polyethylene glycol 3350, magnesium silicate, ferric oxide red, poloxamer 188

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.